Literature DB >> 7494544

Alterations of beta-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure.

M Böhm1.   

Abstract

Alterations of receptor-G-protein-regulated adenylyl cyclase activity have been suggested to represent an important alteration leading to contractile dysfunction in the failing human heart. Recent experiments suggest that the beta 1-adrenoceptor (beta 1 AR) density and mRNA levels are reduced, while beta 2-adrenoceptors and stimulatory G-proteins are unchanged (mRNA and protein level). Functional assays demonstrated that the catalyst of the adenylyl cyclase is not different between failing and nonfailing myocardium. Inhibitory G-proteins are increased (pertussis toxin substrates, protein and mRNA) and correlate to the reduced inotropic effects of beta-adrenoceptor agonists and of cAMP-PDE inhibitors. Gi alpha-coupled m-cholinoceptors and A1-adrenergic receptors are unchanged in density and affinity. Stimulation of these receptors resulted in an unchanged antiadrenergic effect on force of contraction. In conclusion, a downregulation of beta 1 AR and an increase of Gi alpha have been observed as signal transduction alteration in failing human myocardium. These alterations are due to alterations of gene expression in the failing heart and are related to a defective regulation of force of contraction in heart failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494544

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  79 in total

1.  Adenine nucleotides promote dissociation of pertussis toxin subunits.

Authors:  D L Burns; C R Manclark
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

2.  A specific beta gamma-subunit of transducin stimulates ADP-ribosylation of the alpha-subunit by pertussis toxin.

Authors:  H Ohguro; Y Fukada; T Yoshizawa; T Saito; T Akino
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

3.  Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.

Authors:  M Böhm; D Beuckelmann; L Brown; G Feiler; B Lorenz; M Näbauer; B Kemkes; E Erdmann
Journal:  Eur Heart J       Date:  1988-08       Impact factor: 29.983

4.  Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure.

Authors:  T Eschenhagen; U Mende; M Nose; W Schmitz; H Scholz; A Haverich; S Hirt; V Döring; P Kalmár; W Höppner
Journal:  Circ Res       Date:  1992-04       Impact factor: 17.367

5.  Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.

Authors:  M Böhm; B Pieske; P Schnabel; R Schwinger; B Kemkes; W P Klövekorn; E Erdmann
Journal:  J Cardiovasc Pharmacol       Date:  1989-10       Impact factor: 3.105

6.  Binding of ATP by pertussis toxin and isolated toxin subunits.

Authors:  S Z Hausman; C R Manclark; D L Burns
Journal:  Biochemistry       Date:  1990-07-03       Impact factor: 3.162

7.  Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.

Authors:  F Waagstein; K Caidahl; I Wallentin; C H Bergh; A Hjalmarson
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

8.  Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.

Authors:  J Gage; H Rutman; D Lucido; T H LeJemtel
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

9.  Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells.

Authors:  R B Clark; M W Kunkel; J Friedman; T J Goka; J A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline.

Authors:  E Gille; H Lemoine; B Ehle; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

View more
  12 in total

1.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

2.  Alterations of cardiac beta-adrenoceptor mechanisms due to calcium depletion and repletion.

Authors:  Xi Wang; Jingwei Wang; Satoshi Takeda; Vijayan Elimban; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

3.  A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.

Authors:  Jenna L Wang; Jian-Xin Guo; Qi-Yuan Zhang; Jay J-Q Wu; Roland Seifert; Gerald H Lushington
Journal:  Bioorg Med Chem       Date:  2007-02-11       Impact factor: 3.641

Review 4.  Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice.

Authors:  H A Rockman; W J Koch; C A Milano; R J Lefkowitz
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

Review 5.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

Review 6.  Mitral valve reconstruction in the patient with heart failure.

Authors:  S F Bolling
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

7.  Differential nature of cross-talk among three G-coupled receptors regulating adenylyl cyclase in rat cardiomyocytes chronically exposed to receptor agonists.

Authors:  P V Sulakhe; X T Vo; R R Mainra
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

8.  Changes in β-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.

Authors:  Rajat Sethi; Qiming Shao; Bin Ren; Harjot K Saini; Nobuakira Takeda; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

Review 9.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

10.  Intravenous milrinone in treatment of advanced congestive heart failure.

Authors:  Aly M Zewail; Mohammad Nawar; Bojan Vrtovec; Cathy Eastwood; M N Biswajit Kar; Reynolds M Delgado
Journal:  Tex Heart Inst J       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.